Biomark Capital Management Co. LLC — Q1 2017 13F Holdings

Name: Biomark Capital Management Co. LLC — 13F Holdings, Q1 2017
Creator: AlphaSMO
License: https://www.sec.gov/forms

CIK: 0001667082

Total reported value

$8.9M

Full holdings list this quarter

#	Ticker	Issuer	Asset Subclass	Weight	Weight Change	Shares Change
1	✓	Juno Therapeutics	Stock-Other	87.21%	—	—
2	ADMA	Adma Biologics INC	Stock-Healthcare	12.68%	+0.08%	—
3	✓	Mabvax Therapeutics Hldgs In	Stock-Other	0.11%	—	—

Position changes disclosed by Biomark Capital Management Co. LLC for the quarter ending Q1 2017, including ticker, issuer, weight change, shares change, and action
#	Ticker	Issuer	Weight Change	Shares Change	Action
1	✓	Juno Therapeutics	+2.6%	—	Unchanged
2	✓	Mabvax Therapeutics Hldgs In	-0.1%	—	Unchanged
3	ADMA	Adma Biologics INC	-2.5%	—	Unchanged